[Current approach to the treatment of early forms of cervix cancer].
The effectiveness of treatment of early cancer of the uterine cervix (TIS, Tla and Tlb) is subject to evaluation of tumor stage, concomitant diseases and patient's age as well as the degree of neoplastic process and immunologic vigor. Complex treatment should be unoffensive for immunity. Immunodepressive agents should be used in conjunction with immunostimulants.
D001402:B-Lymphocytes / Q000276:immunology; D001918:Brachytherapy; D002278:Carcinoma in Situ / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007157:Immunologic Surveillance / Q000528:radiation effects; D053685:Laser Therapy; D011183:Postoperative Complications; D011379:Prognosis; D011832:Radiation Injuries; D013601:T-Lymphocytes / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy*
Sovremennyĭ podkhod k lecheniiu rannikh form raka sheĭki matki.